Email This Article

Headlines & Perspectives
Biotech Mailbag: Bad CEOs Offer Lessons
By Adam Feuerstein
12/19/08 - 11:08 AM EST
Senior Columnist Adam Feuerstein's selection of Kelly Martin as the worst biotech CEO for 2008 highlights the need for investors to scrutinize management teams before plunging into an investment.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)
Dow Jones S&P 500 NASDAQ 10-Year Note
10,464.40 1,110.63 2,176.05 32.79
Oil *
77.05
UP
30.69
UP
4.98
UP
6.87
DOWN
0.38
10 Yr
3.28%
SPDR Gold
116.62
+0.29%
+0.45%
+0.32%
-1.15%
Data delayed 20 minutes

Brokerage Partners